Pharm 1 USMLE Flashcards Preview

Step 1 Complete > Pharm 1 USMLE > Flashcards

Flashcards in Pharm 1 USMLE Deck (214)
Loading flashcards...
1
Q

28 y/o chemist presents w/ MPTP exposuree. what NT is depleted

A

dopamine

2
Q

woman taking tetracycline exhibits photosensitivity. What are the clinical manifestations?

A

rash on sun exposed retions of body

3
Q

African American man who goes to Africa develops a hemolytic anemia after taking malarial prophylaxis. what is the enzyme deficiency

A

glucose 6 phosphate dehydrogenase

4
Q

farmer presents w/ dyspnea, salivation, miosis, diarrhea, cramping, and blurry vision. What caused this, and what is the MOA

A

insecticide poisoning; inhibition of acetylcholinesterase

5
Q

27 y/o female w/ hx of psych illness now has urinary retention due to a neuroleptic. What do you tx it with?

A

bethancechol

6
Q

pt w/ recent kidney transplant is on cyclosporine for immunosuppression. Requires antifungal agent for candidiasis. What antifungal drug would result in cyclosporine toxicity

A

ketoconazole

7
Q

pt is on carbamazepine. What routine workup should always be done?

A

LFTs

8
Q

23 y/o female who is on rifampin for TB prophylaxis and on birth control (estrogen) gets pregnant. why

A

rifampin augments estrogen metabolism in the liver, rendering it less effective

9
Q

what is the volume of distribution

A

relates the amount of drug in the body to the plasma concentration

=amount of drug in body/plasma drug concentration

10
Q

Vd of plasma protein bound drugs can be altered by dzs in these 2 organ systems

A

liver and kidney

11
Q

what is clearance (CL)

A

relates the rate of elimination to the plasma concentration

Cl=rate of elimination of drug/plasma drug concentration

12
Q

what is the half life (t1/2)

A

the time required to change the amount of drug in the body by 1/2 during elimination (or constant infusion). A drug infused at a constant rate reaches about 94% of steady state after 4 t(1/2_

t(1/2)=0.7xVd/Cl

13
Q

what is concentration of drug in the body after 1 half life

A

50%

14
Q

what is concentration of drug in the body after 2 half lives

A

75%

15
Q

what is concentration of drug in the body after 3 half lives

A

87.5%

16
Q

what is concentration of drug in the body after 4 half lives

A

~94%

17
Q

Cp =

A

target plasma concentration

18
Q

F=

A

bioavalability

19
Q

Loading dose=

A

Cp x Vd/F

20
Q

maintenance dose=

A

CpxCL/F

21
Q

what happens to the loading dose and maitenance dose in pts will impared renal or hepatic fxn

A

loading dose remains the same

maitenence dose is decreased

22
Q

this order elimination describes a constant rate of elimination regardless of C (i.e. constant AMOUNT of drug eliminated per unit time). Cp decreases linearly with time. E.g., etoh, phenytoin, and asprin (at high or toxic concentrations)

A

zero order elimination

image. p. 195

23
Q

this order elimination describes a rate of elimination proportional to the drug concentration (i.e., constant FRACTION of drug eliminated per unit time). Cp decreases exponentially with time.

A

first order elimination

image. p. 195

24
Q

In drugs with 1st order kinetics rate of elimination is ________ plasma concentration (Cp).
image. p. 195

A

proportional to

25
Q

In drugs with 0 order kinetics rate of elimination is ________ plasma concentration (Cp).
image. p. 195

A

independant of

26
Q

give some examples of phase I metabolism

A

reduction, oxidation, hydrolysis.

27
Q

describe the metabolites of phase I metabolism(aka are they active)

A

slightly polar, water soluble, often still active

28
Q

give some examples of phase II metabolism

A

acetylation, glucuronidation, sulfation

29
Q

describe the metabolites of phase II metabolism(aka are they active)

A

yields very polar, inactive metabolites (renally excreted

30
Q

what pump is key in phase I metabolism

A

cytocrome P-450

31
Q

by what method are drugs metabolized in phase II metabolism

A

conjugation

32
Q

what phase of metabolism do geriatric pts lose first

A

phase I

33
Q

competitive antagonist shifts the curve _______

A

to the right

34
Q

noncompetitive antagonist shifts the curve ______

A

downward

35
Q

EC50:

A

dose causing 50% of maximal effect.

36
Q

Kd:

A

concentration of drug required to bind 50% of receptor sites

37
Q

image p. 196-percent of maximum efect as a fx of dose

A

in a system with spare receptors, the EC50 is lower than the Kd, indicating that to achieve 50% of maximum effect, <50% of the receptors must be activated.

38
Q

image p. 197-percent of maximum efect as a fx of dose

A

comparison of dose-response curves for a full agonist and a partial agonist. The partial agonist acts on the same receptor system as the full agonist but cannot produce an equivalently large effect (it has lower maximal efficacy) no matter how much the dose is increased. A partial agonist may be more potent (as in the figure), less potent, or equally potent; potency is an indipendant factor

39
Q

what is the therapeutic index

A

mean toxic dose/mean effective dose

TD50/ED50

high TI is good

40
Q

on average how long does it take for a drug to be in In-vitro stidues

A

2 yts

41
Q

on average how long does it take for a drug to be in animal stidues

A

2 years

42
Q

this phase of clinical testing for a drugs looks at if it is safe, and the pharmakinetics

A

phase 1

43
Q

this phase of clinical testing for a drugs looks at if it works in pts

A

phase 2

44
Q

this phase of clinical testing for a drugs looks at does it work, in a double blind study

A

phase 3

45
Q

this phase drug development involves postmarketing surveillance

A

phase 4

46
Q

On average how many years of drug development does it take to file a NDA (new drug application)

A

9

47
Q

how long after filing of application does patent expire on a drug and generics become available

A

20 years

48
Q

given the receptor, give the G-protein class and the major fx: α1

A

increases vascular smooth mm contraction

G protien class: q

49
Q

given the receptor, give the G-protein class and the major fx: α2

A

Decrease sympathetic outflow, decrease insulin release

G protien class: i

50
Q

given the receptor, give the G-protein class and the major fx: ϐ1

A

increase heart rate, increase contractility, increase renin release, increase lipolysis, incease aqueous humor formation

G protien class: s

51
Q

given the receptor, give the G-protein class and the major fx: ϐ2

A

vasodilation, bronchodilation, increase glucagon release

G protien class: s

52
Q

given the receptor, give the G-protein class and the major fx: M1

A

CNS

G protien class: q

53
Q

given the receptor, give the G-protein class and the major fx: M2

A

decrease heart rate

G protein class: i

54
Q

given the receptor, give the G-protein class and the major fx: M3

A

increase exocrine gland secretions

G protein class: q

55
Q

given the receptor, give the G-protein class and the major fx: D1

A

relaxes renal vascular sm mm

G protein class: s

56
Q

given the receptor, give the G-protein class and the major fx: D2

A

modulates NT release, esp in the brain

G protein class:i

57
Q

given the receptor, give the G-protein class and the major fx: H1

A

increase nasal and bronchial mucus production, contraction of bronchioles, pruritis, and pain

G protein class:q

58
Q

given the receptor, give the G-protein class and the major fx: H2

A

increase gastric acid secretion

G-protein class:s

59
Q

given the receptor, give the G-protein class and the major fx: V1

A

increase vascular sm mm contraction

G-protein class:q

60
Q

given the receptor, give the G-protein class and the major fx: V2

A

increase H2O permeability and reabsorption in the collecting tubules of the kidney
G-protein class:s

61
Q

release of NE from a sympathetic nn ending is modulated by ______, acting on these receptors.

A

NE, ACH, ATN II, othr substances

presynaptic α2 autoreceptors

62
Q

Bethanechol is a cholinomimetic with direct agonist actions. Give its clinical applications

A

postop and neurogenic ileus and urinary retention

it acts by activating Bowel & Bladder smooth mm. It is resistant to AChE

63
Q

Carbachol, pilocarpine is a cholinomimetic with direct agonist actions. Give its clinical applications

A

Used for glaucoma

it activates ciliary mm of eye (open angle), pupillary sphicter (narrow angle); It is resistant to AChe

64
Q

Neostigmine is a cholinomimetic with indirect agonist actions, it acts on anticholinesterases. Give its clinical applications

A

postop & neurogenic ileus and urinary retention, myasthenia gravis, reversal of neuromuscular jxn blockade (postop)

It acts by inceasing endogenous ACh

65
Q

Pyridostigmine is a cholinomimetic with indirect agonist actions, it acts on anticholinesterases. Give its clinical applications

A

used to tx myasthenia gravis

It acts by inceasing endogenous ACh, thereby increasing strength

66
Q

Edrophonium is a Pyridostigmine is a cholinomimetic with indirect agonist actions, it acts on anticholinesterases. Give its clinical applications

A

myasthenia gravis (short acting)

It acts by inceasing endogenous ACh

67
Q

physostigmine is a cholinomimetic with indirect agonist actions, it acts on anticholinesterases. Give its clinical applications

A

glaucoma (crosses blood brain barrier) and atropine OD

works by increasing endogenous ACh

68
Q

Echothiophateis a cholinomimetic with indirect agonist actions, it acts on anticholinesterases. Give its clinical applications

A

Glaucoma

works by increasing endogenous ACh

69
Q

give some signs of cholinesterase inhibitor poisoning

A

Diarrhea (abd cramping), Urination, Miosis, Bronchospasm, Bradycardia, Exitation of skeletal mm and CNS, Lacrimation, Sweating, and Salivation,

mneu: DUMBBELSS
or SLUD effects

70
Q

what can cause cholinesterase inhibitor poisoning

A

Parathion and other organophosphates

71
Q

how do you tx cholinesterase inhibitor poisoning

A

Antidote–atropine (muscarinic antagonist) plus pralidoxime (chemical antagonist used to regenerate active cholinesterase)

72
Q

Atropine, homotropine, and tropicamide are cholinoreceptor blockers taht act on they eye to do what?

A

produce mydriasis and cycloplegia

73
Q

Benzotropine is a cholinoreceptor blocker that acts on the CNS to tx?

A

Parkinson’s dz

74
Q

Scopolamine is a cholinoreceptor blocker that acts on the CNS to tx?

A

Motion skickness

75
Q

Ipratropium is a cholinoreceptor blocker that acts on the Respiratory system to tx?

A

Asthma, COPD

76
Q

Methscopolamine, oxybutin, glycopyrrolateis a cholinoreceptor blocker that acts on the GU system to tx?

A

urgency in mild cystitis and reduce bladder spasms

77
Q

atropine is a muscarinic _______

A

antagoinist

mneu: blocks SLUD:
salivation, Lacrimation, Urination, Defication

78
Q

give the effect atropine would have on the eye

A

pupil dilation, cycloplegia

79
Q

give the effect atropine would have on the airway

A

decrease secretions

80
Q

give the effect atropine would have on the stomach

A

decrease acid secretion

81
Q

give the effect atropine would have on the gut

A

decrease motility

82
Q

give the effect atropine would have on the bladder

A

decrease urgency in cystitis

83
Q

what would an atropine toxicity look like

A

increase body temp; rapid pulse; dry mouth; dry, flushed skin; cycloplegia; constipation; disorientation

SE:  
Hot as a hare
Dry as a bone
Red as a beet
Blind as a bat
Mad as a hatter
84
Q

watch out cuz atropine can cause this in the elderly

A

acute angle-closure glaucoma

85
Q

watch out cuz atropine can cause this in men with BPH

A

urinary retention

86
Q

watch out cuz atropine can cause this in infants

A

hyperthermia

87
Q

mechanism of hexamethonium

A

nicotinic ACh receptor antagoinist

88
Q

hexamethonium clinical use

A

ganglionic blocker. Used in experimental models to prevent vagal reflex responses to changes in blood pressue – e.g., prevents reflex bradycardia caused by NE

89
Q

this catecholamine sympathomimetic is a derect general agonist (α1α2β1β2). It is used for open angle glaucoma, asthma, and hypotension

A

epinephrine

90
Q

this catecholamine sympathomimetic acts on α1α2β1. It is used for hypotension (but decreases renal perfusion)

A

NE

91
Q

this catecholamine sympathomimetic acts on β1=β2. It is used for AV block (rarely)

A

Isoproterenol

92
Q

this catecholamine sympathomimetic acts on D1=D2>β>α. It is used for shock(increases renal perfusion), heart failure

A

Dopamine

93
Q

this catecholamine sympathomimetic acts on β1>B2. It is used for shock and heart failure

A

dobutamine

94
Q

this sympathomimetic is an indirect general agonist which releases stored catecholamines. It is used for narcolepsy, obesity, ADD.

A

amphetamine

95
Q

this sympathomimetic is an indirect general agonist which releases stored catecholamines. It is used for nasal decongestion, urinary incontinance, hypotension

A

ephedrine

96
Q

this sympathomimetic acts on α1>α2. It is used as a pupil dilator, vasoconstrictor, and nasal decongestor.

A

phenylephrine

97
Q

this sympathomimetic acts on β2>β1. It is used for asthma

A

albuterol, terbutaline

98
Q

this sympathomimetic is an indirect general agonist which releases stored and uptake inhibitor . It causes vasoconstriction and local anesthesia

A

cocaine

99
Q

this sympathomimetic is a centrally acting α-agonist which decreases central adrenergic outflow. It is used for hypertension, especially with no renal dz (no decrease in blood flow to the kidney)

A

clonadine

α-methyldopa

100
Q

this nonselective α-blocker is used for pheochromocytoma. Toxicity can cause orthostatic hypotension and reflex tachycardia.

A

Phenoxybenzamine (irreversible) and pentolamine (reversable)

101
Q

This α1 selective blocker is used for hypertension, urinary retension in BPH. Toxicities include 1st dose orthostatic hypotension, idzziness, headache.

A

prazosin, terazosin, doxazosin

102
Q

this α2 selective blocker is used for depression. Toxicity includes sedation, increased serum cholesterol and increased appetite

A

mirtazapine

103
Q

image. p. 204- effects of α-blockers on blood pressure responses to epi and phenylephrine.

A

the peinephrine response exhibits a reversal of the mean BP change, from a net increase (the α response) to a net decrease (the B2 response). The response to phenylephrine is supressed but not reversed because the phenylephrine is a “pure” α agonist w/out B action

104
Q

name some beta blockers

A

propranolol, metoprolol, atenolol, nadolol, timolol, pindolol, esmolol, labetalol

105
Q

how do the β blockers effect hypertension

A

decrease cardiac output, decrease renin secretion

106
Q

how do the β blockers effect angina pectoris

A

decreasee HR & contractility, resulting in less O2 consumption

107
Q

how do the β blockers effect MI

A

decrease mortality

108
Q

how do the β blockers effect SVT (propranolol, esmolol only)

A

decrease AV conduction velocity

109
Q

how do the β blockers effect CHF

A

slows progression of chronic failure

110
Q

how do the β blockers effect glaucoma(timolol only)

A

decreases secretion of aqueous humor

111
Q

give some toxicities of β blockers

A

impotensce, exacerbation of asthma, bradycardia, AV block, CHF, sedation, sleep alteration; use w/ caution in dbts

112
Q

give the nonselective (B1=B2) B blockers

A

propranolol, timolol, nadolol, pindolol (partial agonist), and labetalol (partial agonist)

113
Q

give the B1 selective (B1>B2) B blockers

A

Acebutolol (partial agonist), Betaxolol, Esmolol (short acting), Atenolol, Metoprolol

mneu: A BEAM of B1 blockers

114
Q

this Rx for glaucoma is an α agonist. It acts by increasing the outflow of aqueous humor. Its SE include mydriasis, stinging. This drug should not be used in closed- angle glaucoma

A

epinephrine

115
Q

this Rx for glaucoma is an α agonist. It acts by decreasing aqueous humor synthesis. It does not cause and pupillary or vision changes.

A

Brimonidine

116
Q

this Rx for glaucoma is a β blocker. It acts by decreasing aqueous humor secretion. It does not cause and pupillary or vision changes.

A

timolol, betaxolol, carteolol

117
Q

this Rx for glaucoma is a diuretic. It acts by decreasing aqueous humor secretion due to decreased HCO3- via inhibition of carbonic anhydrase. It does not cause and pupillary or vision changes.

A

Acetazolamide

118
Q

this Rx for glaucoma is a cholinomimetic. It acts by increaseing outflow of aqueous humor by contracting the ciliary mm and opening the trabecular meshwork. SE include miosis and cyclospasm

A

pilocarpine, carbachol, physostigmine, echothiophate

119
Q

this Rx for glaucoma is a prostaglandin. It acts by increaseing outflow of aqueous humor. SE include darkening of the iris (browning)

A

lantanoprost (PGF2α0

120
Q

what is the anitidote/tx for acetaminophen overdose

A

N-acetylcysteine

121
Q

what is the anitidote/tx for salicylate overdose

A

alkanize urine, dialysis

122
Q

what is the anitidote/tx for anticholinesterases, organophosphatesoverdose

A

atropine, pralidoxime

123
Q

what is the anitidote/tx for antimuscarinic, anticholinergic agentsoverdose

A

physostigmine salicylate

124
Q

what is the anitidote/tx for B-blocker overdose

A

glucagon

125
Q

what is the anitidote/tx for digatis overdose

A

stop dig, normalize K+, lidocaine, anti-dig Fab fragments, Mg++

126
Q

what is the anitidote/tx for iron overdose

A

deferoxamine

127
Q

what is the anitidote/tx for lead overdose

A

CaEDTA, dimercaprol, succimer, penicillamine

128
Q

what is the anitidote/tx for arsenic, mercury, gold overdose

A

Dimercaprol (BAL), succimer

129
Q

what is the anitidote/tx for copper, arsenic, gold overdose

A

penicillamine

130
Q

what is the anitidote/tx for cyanide overdose

A

nitrite, hydroxycobalamin, thiosulfate

131
Q

what is the anitidote/tx for methemoglobin overdose

A

methylene blue

132
Q

what is the anitidote/tx for CO overdose

A

100% O2, hyperbaric O2

133
Q

what is the anitidote/tx for methanol, ethylene glycol (antifreeze) overdose

A

ethanol, dialysis, fomepizole

134
Q

what is the anitidote/tx for opiods overdose

A

naloxone/naltrexone

135
Q

what is the anitidote/tx for benzodiazepines overdose

A

flumazenil

136
Q

what is the anitidote/tx for TCAs overdose

A

NaHCO3 (nonspecific

137
Q

what is the anitidote/tx for heparin overdose

A

protamine

138
Q

what is the anitidote/tx for warfarin overdose

A

vitamin K, fresh frozen plasma

139
Q

what is the anitidote/tx for tPA, streptokinase overdose

A

aminocaproic acid

140
Q

give some signs of lead poisioning

A

Lead Lines on gingivae and on epiphyses of long bones on x-ray

Encephalopathy and Erythrocyte basophilic stippling

Abdominal colic and sideroblastic Anemia

Drops–wrist and foot drop

mneu: LEAD

141
Q

what is the tx for Lead poisoning in adults and kids

A

adults: Dimercarol and EDTA
kids: Succimer
mneu: It “sucks” to be a kid with lead poisoning

142
Q

when someone ODs on a weak acid (phenobarbital, methotrexate, aspirine) what do you do

A

alkalinize urine with bicarb to increase clearance

143
Q

when someone ODs on weak bases (e.g., amphetamines) what do you do

A

acidify urine to increase clearance (give NH4Cl)

144
Q

someone comes in with atropine like side effects. What do you suspect

A

tricyclics

145
Q

someone comes in with cardiac toxicity. what do you suspect?

A

doxorubicin (adriamycin), daunorubicin

146
Q

someone comes in with coronary vasospasm. what do you suspect?

A

cocaine

147
Q

someone comes in with cutaneous flushing. what do you suspect?

A

niacin, Ca++ channel blockers, adenosine, vancomycin

148
Q

someone comes in with torsades de pointes. what do you suspect?

A

class III (sotalol, class IA (quinidine) antiarrhythmics, cisapride

149
Q

someone comes in with agranulocytosis. what do you suspect?

A

clozapine, carbamazepine, colchicine

150
Q

someone comes in with aplastic anemia . what do you suspect?

A

chloramphenicol, benzene, NSAIDS

151
Q

someone comes in with grey baby syndrome. what do you suspect?

A

chloramphenicol

152
Q

someone comes in with hemolysis in G6PD-deficient pts. what do you suspect?

A

sulfonamines, isoniazid (INH, aspirin, ibuprofen, primaquine, nitrofurantoine

153
Q

someone comes in with thrombotic complications. what do you suspect?

A

OCPs (e.g., estrogens and progestins)

154
Q

someone comes in with cough. what do you suspect?

A

ACE inhibitors (losartan-no cough)

155
Q

someone comes in with pulmonary fibrosis. what do you suspect?

A

bleomycin, amiodarone, busulfan

156
Q

someone comes in with acute cholestatic hepatitis. what do you suspect?

A

macrolides

157
Q

someone comes in with focal to massive hepatic necrosis. what do you suspect?

A

halothane, valproic acid, acetaminophen, amanita phalloides

158
Q

someone comes in with hepatitis. what do you suspect?

A

INH

159
Q

someone comes in with pseudomembranous colitis. what do you suspect?

A

clindamycin, ampicillin

160
Q

someone comes in with adrenocortical insufficency. what do you suspect?

A

glucocorticoid withdrawal (HPA supression

161
Q

someone comes in with gynomastia. what do you suspect?

A

Spironolactone, Digitalis, Cimetidine, Alcoholism, estrogens, Ketoconazole

mneu: Some Drugs Create Awesom Knockers

162
Q

someone comes in with hot flashes. what do you suspect?

A

tamoxifin

163
Q

someone comes in with gingival hyperplasia. what do you suspect?

A

phenytoin

164
Q

someone comes in with osteoporosis. what do you suspect?

A

corticosteroids, heparin

165
Q

someone comes in with photosensitivity. what do you suspect?

A

Sulfonamindes, Amiodarone, Tetracycline

mneu: SAT for a photo

166
Q

someone comes in with SLE like syndrome. what do you suspect?

A

Hydralazine, INH, Procainamide, Phenytoin

mneu: it’s not HIPP to have lupus

167
Q

someone comes in with tendonitis, tendon rupture, and cartilage damage (kids). what do you suspect?

A

fluoroquinolones

168
Q

someone comes in with Fanconi’s syndrome. what do you suspect?

A

expired tetracycline

169
Q

someone comes in with interstitial nephritis. what do you suspect?

A

methacillin

170
Q

someone comes in with hemorrhagic cystitis. what do you suspect?

A

cyclophosphamide, ifosfamide

171
Q

someone comes in with cinchonism. what do you suspect?

A

quinidine, quinine

172
Q

someone comes in with diabetes insipidus. what do you suspect?

A

lithium, demeclocycline

173
Q

someone comes in with seizures. what do you suspect?

A

bupropion, imipenem/cilastin

174
Q

someone comes in with tarditive dyskinesia. what do you suspect?

A

antipsychotics

175
Q

someone comes in with disulfram-like reaction. what do you suspect?

A

metronidazole, certain cephalosporins, procarbazine, sulfonyurease

176
Q

someone comes in with nephrotoxicity/neurotoxicity. what do you suspect?

A

polymyxins

177
Q

someone comes in with nephrotoxicity/ototoxicity. what do you suspect?

A

aminoglycosides, loop diuretics, cysplatin

178
Q

P-450 inducers

A
Quinidine
Barbituates
Phenytoin
Rifampin
Griseofulvin
Carbamazapine

mneu: Queen Barb takes Phen-Phen and Refuses Greasy Carbs

179
Q

P-450 inhibitors

A
Isoniazid
Sulfonamides
Cimetidine
Ketoconazole
Erythromycin
Grapefruit juice
St. John's wort

mneu: Inhibitors Stop Cyber Kids from Eating GrapefruitS

180
Q

ethylene glycol is transformed into oxalic acid by alcohol dehydrogenase which can have this result

A

acidosis, nephrotoxicity

181
Q

methanol is transformed into formaldehyde and formic acid by alcohol dehydrogenase which can have this result

A

severe acidosis, retinal damage

182
Q

ethanol is transformed into acetic acid and acetaldehyde by alcohol dehydrogenase. Acetaldehyde can have this result

A

nausea, vomiting, headache, hypotension

183
Q

ethanol is a competitive substrate for this hormone

A

ADH

184
Q

this herbal agent is sometimes used for the common cold. Toxicities can be GI distress, dizziness, and headache

A

echinacea

185
Q

this herbal agent is sometimes used as a stimulent. Toxicities can be CNS and CV stimulation, arrhythmias, stroke, and seizures at high doses

A

ephedra

186
Q

this herbal agent is sometimes used for migranes. Toxicities can be GI distress, ulcers, antiplatelet actions

A

feverfew

187
Q

this herbal agent is sometimes used for the intermittent claudication. Toxicities can be GI distress, anxiety, insomnia, headache, and antiplatelet action

A

ginkgo

188
Q

this herbal agent is sometimes used for anxiety. Toxicities can be GI distress, sedation, ataxia, hepatotoxicity, phototoxicity, dermatotoxicity

A

Kava

189
Q

this herbal agent is sometimes used for viral hepatitis. Toxicities can be loose stools

A

milk thistle

190
Q

this herbal agent is sometimes used for BPH. Toxicities can be GI distress, decreased libido, hypertension

A

Saw palmetto

191
Q

this herbal agent is sometimes used for mild to moderate depression. Toxicities can be GI distress, phototoxicity, serotonin syndrome with SSRI, inhibits P-450 system

A

St. Johns wart

192
Q

this herbal agent is sometimes used for symptomatic improvement in females with SLE or AIDS. Toxicities can include androgenization (premenopausal women), estrogenic effects (postmenopausal), feminization (young men)

A

Dehydroepiandrosterone

193
Q

this herbal agent is sometimes used for jet lag and sinsomnia. Toxicities can be sedation, suppresses midcycle LH, hypoprolactemia

A

melatonin

194
Q

drugs ending in -afil, are usually for . . .

A

erectile dysfunction

e.g., Sildenafil

195
Q

drugs ending in -ane, are usually for . . .

A

inhalational general anesthetic

e.g., halothane

196
Q

drugs ending in -azepam, are usually . . .

A

benzodiazepines

e.g. diazepam

197
Q

drugs ending in -azine, are usually . . .

A

phenothiazines (neuroleptics, antiemetics)

e.g., chlorpromazine

198
Q

drugs ending in -azole, are usually . . .

A

antifungals

e.g., ketoconazole

199
Q

drugs ending in -barbital, are usually . . .

A

barbiturates

e.g., phenobarbital

200
Q

drugs ending in -caine, are usually . . .

A

local anesthetics

e.g., lidocaine

201
Q

drugs ending in -cillin, are usually . . .

A

penicillins

e.g., methicillin

202
Q

drugs ending in -cycline, are usually . . .

A

antibiotic, protein synthesis inhibitors

e.g., tetracycline

203
Q

drugs ending in -ipramine, are usually . . .

A

TCA

e.g., imipramine

204
Q

drugs ending in -navir, are usually . . .

A

protease inhibitors

e.g., saquinavir

205
Q

drugs ending in -olol, are usually . . .

A

Beta agonist

e.g., propranolol

206
Q

drugs ending in -operidol, are usually . . .

A

Butyrophenones (neuroleptics)

e.g., haloperidol

207
Q

drugs ending in -oxins, are usually . . .

A

cardiac glycosides (inotropic agents)

e.g., digoxin

208
Q

drugs ending in -phylline, are usually . . .

A

methylxanthine

e.g., theophylline

209
Q

drugs ending in -pril, are usually . . .

A

ACE inhibitors

e.g., Captopril

210
Q

drugs ending in -terol, are usually . . .

A

beta2 agonist

e.g., albuterol

211
Q

drugs ending in -tidine, are usually . . .

A

H2 antagonist

e.g., cemetidine

212
Q

drugs ending in -triptyline, are usually . . .

A

TCA

e.g., amitriptyline

213
Q

drugs ending in -tropin, are usually . . .

A

pituitary hormone

e.g., somatotropin

214
Q

drugs ending in -zosin, are usually . . .

A

alpha1 antagonist

e.g., prazosin